Sotevtamab, the novel bispecific antibody , is generating significant interest within the oncology community, particularly regarding its promise for treating hematologic 2411526-47-9 cancers. This therapy functions by concurrently engaging CD3 and the tumor-associated antigen, such as CD19, to stimulating the body's response to can eliminate malign

Ibritumomab, known as Zevalin, represents the novel form of precision radiotherapy applied to combat certain types of cancers, particularly previously treated follicular lymphoma cases . This is a monoclonal molecule conjugated to yttrium-90 , a radioisotope that releases precise radiation directly within cancerous cells. Compared to traditional ch